Live briefing
Everything about Avast
Czech security software company
Avast Software s.r.o. is a subsidiary of Gen Digital. It is a Czech multinational cybersecurity software company headquartered in Prague, Czech Republic, that researches and develops computer security software, machine learning, and artificial intelligence. Avast had more than 435 million monthly active users and the second largest market share among anti-malware application vendors worldwide as of April 2020. As of 2025, parent company Gen Digital had approximately 4,000 employees worldwide. Wikipedia →
🧭 Start here: a 6-step reading path
- Read the overview: AvastA 5-minute orientation
- Skim a recent paper: Vnímání vzdělávání v tématu sociálního inženýrství ve společnosti AvastInfluential work since 2022
- Pick up a classic book: Zend-AvestaThe most-reprinted book on the subject
- Read the landmark paper: Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 studyCited 94 times
- Go sideways: Avast AntivirusA closely related topic
- Go sideways: AVG TechnologiesA closely related topic
📖 Definitions
Interjection Hold fast! Cease! Stop! Desist! Wait!
Interjection Listen! Pay attention!
🗂️ The subject at a glance
🏆 Landmark papers (most cited)
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
AVAST survey 0.4–1.0 μm spectroscopy of igneous asteroids in the inner and middle main belt
Arterial cerebral blood volume-weighted functional MRI using pseudocontinuous arterial spin tagging (AVAST)
Molecular basis for anti-jumbo phage immunity by AVAST type 5
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: Final results for the AVAST-M trial.
Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: Preplanned interim results for the AVAST-M trial.
🆕 Influential since 2022
📚 Books worth reading
Zend-AvestaGustav Theodor Fechner · 1851
Ranked by number of editions on Open Library, a rough measure of how lasting a book is.
🔗 Related topics
- Avast Antivirus Avast Antivirus is a platform of cross-platform internet security applications developed by Avast, a subsidiary of Gen Digital Inc.. It is available on…
- AVG Technologies AVG Technologies B.V. is a brand of cybersecurity, privacy, performance and utility software applications for desktop computers and mobile devices developed…
- AVG AntiVirus AVG AntiVirus (previously known as AVG, an abbreviation of Anti-Virus Guard) is a line of antivirus software developed by AVG Technologies, a subsidiary…
- Norton (software) Norton is a family of computer products and software focused on digital security, privacy, identity protection, and utilities. It is owned by the American…
- Pavel Baudiš Pavel Baudiš (born May 1960)is a Czech software engineer, entrepreneur and the co-founder of Avast along with Eduard Kučera. He became the largest Gen…
- Avira Avira Operations GmbH & Co. KG is a German multinational computer security software company mainly known for its Avira Free Security antivirus software…
- CCleaner CCleaner (/ˈsiːˌkliːnər/; originally meaning "Crap Cleaner"), developed by Piriform Software, is a utility used to clean potentially unwanted files and…
- Gen Digital Gen Digital Inc. (formerly Symantec Corporation and NortonLifeLock Inc.) is a multinational software company co-headquartered in Tempe, Arizona, United…